In this report, the global leukapheresis products market is segmented by type, application, end user, and region. By type, the global leukapheresis products market is segmented into leukapheresis devices and disposables. The leukapheresis devices segment is expected to register the highest CAGR during the forecast period. The growth of this segment can be attributed to the increasing number of therapeutic leukapheresis procedures conducted for the treatment of leukemia, immune-mediated inflammatory diseases, and inflammatory bowel disease.
Factors such as rising incidence and prevalence of leukemia and a growing demand for leukopaks are the key factors driving the growth of the leukapheresis market. In addition, the number of blood donations has grown in recent years, thereby ensuring the steady uptake of apheresis for the separation of blood components. The use of leukapheresis in pediatric patients is also being explored, making this an area of opportunity in the market. However, the high cost of therapeutic leukapheresis and leukopaks, the stringent regulations for leukocyte donor recruitment, and complications associated with therapeutic leukapheresis may restrain the growth of this market to a certain extent.
Market growth can be attributed to the increasing incidence and prevalence of leukemia, growing demand for leukopaks for research applications, and increasing blood donations. However, the high cost of therapeutic leukapheresis and leukopaks, stringent donor recruitment criteria, the dearth of skilled professionals, and complications associated with therapeutic leukapheresis can hinder the growth of this market.
Request Research Sample: https://www.marketsandmarkets.com/requestsample.asp?id=20283148
On the basis of applications, the leukapheresis products market is segmented into research applications and therapeutic applications. The research application segment accounted for the fastest growth in the leukapheresis products market during the forecast period. The growth of this segment can be attributed to increasing adoption of leukapheresis for the isolation of WBCs for research applications such as the development of cell-based immunotherapies.
Terumo BCT is a leading player in the leukapheresis products market and accounted for the largest share of the market in 2017. The company offers apheresis equipment with the WBC removal protocol. The company has a strong geographic presence through its various subsidiaries established across the globe—Terumo BCT Latin America S.A. in Argentina, Terumo BCT Europe N.V. in Belgium, and Terumo BCT (Asia Pacific) Ltd. in Hong Kong. The company focuses on expanding its presence to new and emerging economies like Vietnam, Belgium, and Northern Ireland. In July 2014, the company opened a manufacturing facility near Ho Chi Minh City, Vietnam.
Company Name: MarketsandMarkets
Contact Person: Mr. Shelly Singh
Email: Send Email
Address:630 Dundee Road Suite 430
Country: United States